An interventional study of Ventro-Cephalic Translatoric Glide and Dorso-Caudal Translatoric Glide in Cervicogenic Headache, sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 44 Years. Per ClinicalTrials.gov, last updated 2025-06-16.
Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment
This study is a randomised control trial and the purpose of this study is to compare ventro-cephalic to dorso-caudal translatoric glides in management of cervicogenic headache.
Participants will be recruited into their respective groups using a coin toss method.Cervicogenic headache will be assesed using International Classification of Headache Disorders, 3rd edition:
A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.
C- Evidence of cause of headache demonstrated by at least 2 of these:
CEH subject selection is based on clinical criteria, however anaesthetic blockades is not used as a criterion.
192 studies on the registry are indexed under Post-Traumatic Headache; 54 are open to participants now.
This study's planned enrollment of 40 is close to the median of 44 across 169 interventional studies indexed under Post-Traumatic Headache.
Browse Post-Traumatic Headache studies →Foundation University Islamabad is the lead sponsor of 255 studies on the registry; 142 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age 18 to 44 years old
C- Evidence of cause of headache demonstrated by at least 2 of these:
Exclusion Criteria:
Participants of group A will receive ventro-cephalic translatoric glide, total of 3 sets with 15 repetitions per set. Duration (5 treatment sessions per week for 2 weeks)
Procedure: Ventro-Cephalic Translatoric Glide
Participants of group B will receive Dorso-caudal translatoric glide, total of 3 sets with 15 repetitions per set. Duration (5 treatment sessions per week for 2 weeks)
Procedure: Dorso-Caudal Translatoric Glide
Participants of group A will receive ventro-cephalic translatoric glides, total of 3 sets with 15 repetitions per set. PROCEDURE: 1. Patient sits on low chair with back straight and therapist stand facing the patient's right side. 2. Therapist's stable hand: with the thumb and index finger of left hand fixate caudal vertebra. 3. Therapist's moving hand: therapist will place his/her right hand on left side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved. 4. Apply glide in ventro-cranial direction in the right angle of the treatment plane of the facet joint.
Participants of group B will receive Dorso-caudal translatoric glides, total of 3 sets with 15 repetitions per set. PROCEDURE: 1. Patient sits on low chair with back straight and therapist stand facing the patient's left side. 2. Therapist's stable hand: with the thumb and index finger of right hand fixate caudal vertebra. 3. Therapist's moving hand: therapist will place his/her left hand on right side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved. 4. Apply glide in dorso-caudal direction in the right angle of the treatment plane of the facet joint.
Headache intensity
It will be measured on a numeric pain rating scale where participant select number ranging from 0 to 10 based on pain intensity, with 0 representing no pain and 10 denotes extreme pain.
Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks.
Headache disability
It will be measured using headache disability index (HDI) which is a 25 item self-rated questionnaire in which participants rate their headache disability by selecting an option from 1 to 3 (yes= 4 points, sometimes= 2 points, and No = 0 point) then sum of responses is used to get final score. Interpretation: 10 to 28= mild disability 30 to 48= moderate disability 50 to 68= severe disability 72 or more= complete disability
Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks
Quality of Life of patient
It will be measured using headache impact test (HIT-6), this tool is used to measure impact of headache on ability to function, a 6 items self-rated questionnaire in which participant select an option from 1 to 5 (Never= 6 points, rarely= 8, sometimes= 10, very often= 11, always= 13) then sum of responses is used to get final score. Interpretation: 60 or more= Very severe impact 56 to 59= Substantial impact 50 to 55= Some impact 49 or less= Little or no impact
Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks
Headache Frequency
It will be measured using medical diary, which is a self-reported measure in which the patient will be asked to report the number of headache days per week through a medical logbook, which will be recorded every day and night.
Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks
Cervical range of motion
It will be measured using CROM instrument a plastic frame device that is fastened to the head with help of Velcro-strap, it consist of 3 separate inclinometers that are fixed to frame (1 in sagittal plan which evaluates range of motion in flexion and extension, where 2nd in frontal plane which evaluates range of motion in side bending, and 3rd in horizontal plan which indicates range of motion in rotation)
Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks
Cervical flexion rotation test
It is used to evaluate impairment of cervical function as the diagnostic criterion of internation headache society (IHS) consist of subjective feathers which includes impairments at atlanto-axial motion segments which is assessed by cervical flexion rotation test.
Time frame: Variable will be evaluated at baseline and then weekly for next 2 weeks
Started Jul 2024 (actual). Primary completion is estimated for Jun 2025, 11 months after the start.
Of 89 non-industry interventional studies with no phase under Post-Traumatic Headache, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 11 months is close to that.
Counting every sponsor, half of 90 studies reached it within 12 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Foundation University Islamabad →